ІМАТИНІБ МЕДАК
Analogs of ІМАТИНІБ МЕДАК
Find cheaper analogs and generic equivalents for ІМАТИНІБ МЕДАК.
Active Ingredient: Imatinib
Product Overview
About ІМАТИНІБ МЕДАК
ІМАТИНІБ МЕДАК is a medication that contains the active ingredient Imatinib, which is used to treat certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific enzymes involved in cancer cell growth. This medication is primarily used to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Key Benefits & Uses
- Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML)
- Treatment of gastrointestinal stromal tumors (GISTs)
- Blocking of specific enzymes involved in cancer cell growth, leading to reduced tumor size and slowed disease progression
Active Ingredient & Action
Imatinib, the active ingredient in ІМАТИНІБ МЕДАК, works by selectively inhibiting certain tyrosine kinases, including BCR-ABL, c-Kit, and PDGFR. This inhibition blocks the proliferation of cancer cells, leading to reduced tumor size and slowed disease progression. Imatinib is taken orally, and its effects can be seen in a matter of weeks, making it a valuable treatment option for patients with CML and GISTs.
Important Notes
Patients taking ІМАТИНІБ МЕДАК should follow the prescribed dosage and treatment schedule closely. It is essential to monitor liver function, complete blood counts, and other laboratory tests regularly during treatment. Additionally, patients should be aware of potential side effects, such as nausea, vomiting, and diarrhea, and report any severe or persistent symptoms to their healthcare provider.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.